SCHEMBL20922867

SCHEMBL20922867

CC1(C)OB(c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c(F)c2)OC1(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 9/20 0.51
▸ LPL P06858 8/20 0.51
▸ ROCK1 Q13464 1/20 0.41
▸ IDO1 P14902 1/20 0.38
▸ TDO2 P48775 1/20 0.38
▸ P4HB P07237 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ DGAT1 O75907 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20922861 0.90 LIPG (0.51) LIPGLPLROCK1IDO1TDO2
SCHEMBL31642888 0.88 LIPG (0.55) LIPGLPLIDO1TDO2P4HB
SCHEMBL31642580 0.86 LIPG (0.54) LIPGLPLIDO1TDO2P4HB
SCHEMBL5899457 0.86 LIPG (0.60) LIPGLPLROCK1P4HBPDGFRB
SCHEMBL27296159 0.84 LIPG (0.51) LIPGLPLIDO1TDO2P4HB
SCHEMBL12424884 0.81 LIPG (0.77) LIPGLPLP4HBL3MBTL1DGAT1
SCHEMBL20655111 0.81 LIPG (0.48) LIPGLPLROCK1IDO1TDO2
SCHEMBL31642860 0.81 LIPG (0.61) LIPGLPLP4HBL3MBTL1DGAT1
SCHEMBL31642814 0.81 LIPG (0.48) LIPGLPLP4HBL3MBTL1PDGFRB
SCHEMBL26582245 0.81 LIPG (0.48) LIPGLPLP4HBDGAT1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301186-A1 ORGANIC TRIAZINE CONTAINING MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230301186-A1 ORGANIC TRIAZINE CONTAINING MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
WO-2020166825-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2020-08-20 — — WO disclosed
EP-3473620-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-02-26 — — EP disclosed
EP-3473620-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-04-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301186-A1 ORGANIC TRIAZINE CONTAINING MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OXER1, OXSR1, OR10J3 LIPG 4695/4885LPL 4793/4885ROCK1 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback